HK1005878A1 - 17B-aryl and 17B-heterocyclyl-5-beta 14-beta-andostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same - Google Patents

17B-aryl and 17B-heterocyclyl-5-beta 14-beta-andostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same

Info

Publication number
HK1005878A1
HK1005878A1 HK98104947A HK98104947A HK1005878A1 HK 1005878 A1 HK1005878 A1 HK 1005878A1 HK 98104947 A HK98104947 A HK 98104947A HK 98104947 A HK98104947 A HK 98104947A HK 1005878 A1 HK1005878 A1 HK 1005878A1
Authority
HK
Hong Kong
Prior art keywords
beta
heterocyclyl
aryl
preparation
pharmaceutical compositions
Prior art date
Application number
HK98104947A
Other languages
English (en)
Inventor
Nicoletta Alimirante
Luigi Bernardi
Alberto Cerri
Piero Melloni
Gloria Padoani
Luisa Quadri
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1005878A1 publication Critical patent/HK1005878A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98104947A 1992-09-29 1998-06-05 17B-aryl and 17B-heterocyclyl-5-beta 14-beta-andostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same HK1005878A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4232638A DE4232638C2 (de) 1992-09-29 1992-09-29 17-Phenyl-5beta-14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
HK1005878A1 true HK1005878A1 (en) 1999-01-29

Family

ID=6469142

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104947A HK1005878A1 (en) 1992-09-29 1998-06-05 17B-aryl and 17B-heterocyclyl-5-beta 14-beta-andostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same

Country Status (12)

Country Link
US (1) US5567694A (xx)
EP (1) EP0590272B1 (xx)
JP (1) JPH06192286A (xx)
KR (1) KR940007055A (xx)
AT (1) ATE147077T1 (xx)
CA (1) CA2106917A1 (xx)
DE (2) DE4232638C2 (xx)
DK (1) DK0590272T3 (xx)
ES (1) ES2095531T3 (xx)
GR (1) GR3022376T3 (xx)
HK (1) HK1005878A1 (xx)
ZA (1) ZA937085B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510340A (en) * 1992-06-12 1996-04-23 Sri International Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
DE4232681C2 (de) * 1992-09-29 1994-11-24 Sigma Tau Ind Farmaceuti 17-Phenyl- und 17-Furyl-14beta,5alpha-androstan- und androsten- Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
US20040242618A1 (en) 2003-04-01 2004-12-02 Lardy Henry A. Antiandrogens with marginal agonist activity and methods of use
CN101291950B (zh) * 2005-09-15 2013-01-02 科学与工业研究会 咪唑基取代的类固醇和茚满-1-酮衍生物
SI2160190T1 (sl) * 2007-06-07 2015-12-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Derivati 5 beta, 14 beta-androstana, uporabni za zdravljenje bolezni zaradi fibroze organov
US20120028945A1 (en) 2009-03-23 2012-02-02 Patrizia Ferrari 5-Beta, 14-Beta-Androstane Derivatives Useful For The Treatment Of Proteinuria, Glomerulosclerosis And Renal Failure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2614046C2 (de) * 1976-04-01 1984-08-02 Boehringer Mannheim Gmbh, 6800 Mannheim Neue 17α-Hydroxy-Cardenolid-Glykoside, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
FR2407940A1 (fr) * 1977-11-08 1979-06-01 Roussel Uclaf Nouveaux derives steroides 17 a-aryle, ou 17 a-heteroaryle, leur procede de preparation et leur application comme medicament
DE3223735A1 (de) * 1982-06-25 1983-12-29 Boehringer Mannheim Gmbh, 6800 Mannheim Neue derivate von 17(alpha)-hydroxy-digitoxigenin-digitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneitmittel
JPH0368596A (ja) * 1989-08-09 1991-03-25 Snow Brand Milk Prod Co Ltd 14α‐ヒドロキシ‐4‐アンドロステン‐3,6,17‐トリオンの製造方法

Also Published As

Publication number Publication date
DE69307071T2 (de) 1997-05-22
EP0590272B1 (en) 1997-01-02
DK0590272T3 (da) 1997-04-14
KR940007055A (ko) 1994-04-26
ATE147077T1 (de) 1997-01-15
DE4232638A1 (de) 1994-03-31
JPH06192286A (ja) 1994-07-12
ZA937085B (en) 1994-08-11
EP0590272A2 (en) 1994-04-06
DE4232638C2 (de) 1994-11-17
CA2106917A1 (en) 1994-03-30
ES2095531T3 (es) 1997-02-16
US5567694A (en) 1996-10-22
DE69307071D1 (de) 1997-02-13
EP0590272A3 (en) 1994-07-06
GR3022376T3 (en) 1997-04-30

Similar Documents

Publication Publication Date Title
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
CA2198599A1 (en) Salts of an Anti-Migraine Indole Derivative
ZA937112B (en) 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstaniene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions contning same
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HK1009139A1 (en) New 6-hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
HUT53363A (en) Process for producing new perhydroazacycloalkano(1,2-a)imidazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
EP0590272A3 (en) 17-aryl and 17-heterocyclyl-5-beta, 14-beta-andostane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
ZA935865B (en) 17-(3-furyl) and 17-(4-pyridazinyl)-5Béta 14Béta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
ZA935866B (en) New 17-hydroxyiminomethyl-5B 14 B-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
ZA954826B (en) New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
IL106107A0 (en) Imidazolyl-substituted cyclohexane derivatives,their preparation and pharmaceutical compositions containing them
GR3029466T3 (en) 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
GR3021998T3 (en) New cyclopentanperhydrophenanthren-17beta-(hydroxy or alkoxy)-17alpha-(aryl or heterocyclyl)-3beta-derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
HK1009334A1 (en) New 17(3-imino-2-alkyl-propenyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
GR3031908T3 (en) Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
DE69701605D1 (de) Im kardiovaskulären System aktive seco-D-Steroide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
GR3024707T3 (en) Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)